Sporozoites

Sporozoites are produced via sporogony (sexual reproduction followed by sporulation) within the mosquito vector's gut wall, forming oocysts on the exterior of the mosquito midgut. Upon rupture of the oocyst, sporozoites migrate to the mosquito's salivary glands, from which they are injected into the human host during a blood meal. Once in the bloodstream, sporozoites rapidly (within ~30 minutes) invade hepatocytes, where they undergo asexual replication (schizogony) to form tissue schizonts containing thousands of merozoites—this is the exoerythrocytic (pre-erythrocytic) cycle. In Plasmodium vivax and P. ovale, some sporozoites can become dormant hypnozoites in the liver, causing relapsing malaria months to years later; this does not occur with P. falciparum or P. malariae. Clinically, sporozoites are asymptomatic during the liver stage (incubation period), and symptoms only manifest once merozoites are released into the bloodstream and invade RBCs (erythrocytic cycle), causing the classic cyclic fevers, chills, and hemolytic anemia. Drugs like primaquine and tafenoquine target liver hypnozoites (radical cure), while atovaquone-proguanil and primaquine also have causal prophylactic activity against developing liver-stage parasites. Diagnosis of malaria via blood smear identifies erythrocytic stages (trophozoites, schizonts, gametocytes), not sporozoites, since sporozoites are transient and not found in peripheral blood. Other apicomplexan parasites (e.g., Toxoplasma gondii, Cryptosporidium) also produce sporozoites within oocysts as part of their life cycles, relevant to fecal-oral transmission and immunocompromised patient infections.